LONDON (MarketWatch) -- Danish drugmaker Novo Nordisk said Friday that it's confident it has secured the long-term sustainability of key franchises within diabetes, the haemophilia inhibitor segment and growthhormone. The firm also said that new data from a 14-week extension of the Lead 6 phase 3b study on obesity treatment liraglutide will be presented. Headline data from the study showed that patients who switched from exenatideto liraglutide experienced statistically significant benefits. The phase 3 programme for liraglutide in obesity is expected to be initiated before the end of 2008.M...
SAVANNAH, GA (MARKET WIRE) PureSpectrum, Inc. (PINKSHEETS: PSPM) has agreed to be a sponsor and an exhibitor on November 5-6 at the 2008 Energy Efficiency and Sustainability Symposium in Atlanta....
The University of British Columbia has earned top grade among Canadian post-secondary institutions and third overall in the College Sustainability Report Card, released today by the Sustainable Endowments Institute....
South African oil and gas giant Sasol has been listed on the Dow Jones Sustainability World Index (DJSI), the company said on Thursday. This is a great achievement for Sasol ... It is the first time that we have been listed on this renowned in...
